Today's Research: Life Technologies, Opko Health, Medicines, and DaVita

   Today's Research: Life Technologies, Opko Health, Medicines, and DaVita

PR Newswire

LONDON, July 25, 2013

LONDON, July 25, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

On Wednesday, July 24, 2013, shares in the healthcare sector ended mostly
lower, tracking the broader market which also closed in the red. The major
movers in the sector included Life Technologies Corp. (NASDAQ: LIFE), Opko
Health Inc. (NYSE: OPK), The Medicines Company (NASDAQ: MDCO), and DaVita
Healthcare Partners Inc. (NYSE: DVA). AAAResearchReports.com has completed
their technical analysis on LIFE, OPK, MDCO, and DVA and these free reports
are accessible by registering at:

http://www.aaaresearchreports.com/register/ 

Shares in Life Technologies Corp. ended slightly lower on Wednesday, finishing
at $74.52, down 0.07% from its previous closing price. The company's shares
fluctuated between $74.52 and $74.73. A total of 1.69 million shares were
traded which is below the daily average volume of 1.79 million. Life
Technologies' shares are currently trading near their 52-week high of $74.81.
The stock has gained 0.70% in the last one month and 1.11% in the last three
months. Sign up for free technical research on LIFE at:

http://www.AAAResearchReports.com/LIFE072513.pdf

Opko Health Inc.'s stock fell sharply on Wednesday, tracking losses in the
broader market. The company's shares ended the day 1.94% lower at $7.57 after
fluctuating between $7.47 and $7.77. A total of 1.86 million shares were
traded which is above the daily average volume of 1.53 million. Despite
Wednesday's pullback, Opko Health's shares have gained 9.39% in the last one
month and 8.76% in the last three months, hence outperforming the S&P 500
during the respective periods. Moreover, the stock is currently trading near
its 52-week high of $7.83. Be sure to read our latest technical research on
OPK by registering at:

http://www.AAAResearchReports.com/OPK072513.pdf

Shares in The Medicines Company tumbled on Wednesday, ending the session 5.05%
lower at $29.73 after fluctuating between $29.52 and $32.60. A total of 1.81
million shares were traded which is below the daily average volume of 758,839.
The company's shares have fallen by 7.18% in the last one month and 11.15% in
the last three months as compared to a gain of 7.17% and 6.79% in the S&P 500
during the respective periods. The stock is trading above its 200-day moving
average. Sign up and read the complimentary report on MDCO at:

http://www.AAAResearchReports.com/MDCO072513.pdf

DaVita Healthcare Partners Inc.'s stock edged lower on Wednesday, tracking
losses in the broader market. The company's shares oscillated between $117.04
and $118.97. A total of 538,902 shares were traded which is below the daily
average volume of 1.00 million. DaVita's shares have fallen by 4.43% in the
last one month and 3.56% in the last three months. However, the stock is
trading slightly above its 200-day moving average. The free report on DVA can
be downloaded by signing up now at:

http://www.AAAResearchReports.com/DVA072513.pdf

----

EDITOR NOTES:

1.This is not company news. We are an independent source and our views do
    not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
    basis and reviewed by a CFA. However, we are only human and are prone to
    make mistakes. If you notice any errors or omissions, please notify us
    below.
3.This information is submitted as a net-positive to companies mentioned, to
    increase awareness for mentioned companies to our subscriber base and the
    investing public.
4.If you wish to have your company covered in more detail by our team, or
    wish to learn more about our services, please contact us at
    pubco@EquityNewsNetwork.com.
5.For any urgent concerns or inquiries, please contact us at
    compliance@EquityNewsNetwork.com.
6.Are you a public company? Would you like to see similar coverage on your
    company? Send us a full investors' package to
    research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.

SOURCE AAA Research Reports

Contact: AAAresearchreports.com Phone #: + 1 (646) 396-9126
 
Press spacebar to pause and continue. Press esc to stop.